Considering India is battling not just a deadly virus, but also a crumbling health infrastructure, people are ready to try any means of survival during this critical time. As the country experiences a high spike in the number of cases, Dr. Randeep Guleria, the director of the All India Institute of Medical Sciences (AIIMS) Delhi said on Monday, “Remdesivir isn’t magic bullet and isn’t a drug that decreases mortality.”
“We may use Remdesivir as we don’t have an anti-viral drug. Remdesivir was proven useful for those in hospitals and on oxygen…it can’t be taken like a regular antibiotic,” he added.
He further emphasized that the anti-viral drug must only be given to people who are hospitalised, have a fall in oxygen saturation and have infiltrates on the chest X-ray or CT-scan.
That said, while social media is swamped with requests for Remdesivir, some reports suggest that the prices of Remdesivir have shot up in the black market and are being sold at unreasonable price to desperate patients.